相似文献
1
PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
J Clin Microbiol. 2007 Jul;45(7):2316-20. doi: 10.1128/JCM.00203-07. Epub 2007 May 16.
2
Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Neurology. 2005 Nov 8;65(9):1376-81. doi: 10.1212/01.wnl.0000176914.70893.14. Epub 2005 Sep 14.
3
Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
Muscle Nerve. 2006 Feb;33(2):225-31. doi: 10.1002/mus.20457.
4
Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
J Neuroimmunol. 2005 Aug;165(1-2):179-85. doi: 10.1016/j.jneuroim.2005.04.013.
5
A Campylobacter jejuni gene associated with immune-mediated neuropathy.
Nat Med. 2001 Jul;7(7):752-3. doi: 10.1038/89831.
6
Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes.
Biochemistry. 2007 Jan 9;46(1):36-44. doi: 10.1021/bi062001v.
7
[Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Rinsho Byori. 1999 Aug;47(8):713-8.
8
Exchange of lipooligosaccharide synthesis genes creates potential Guillain-Barre syndrome-inducible strains of Campylobacter jejuni.
Infect Immun. 2006 Feb;74(2):1368-72. doi: 10.1128/IAI.74.2.1368-1372.2006.
9
Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources.
J Clin Microbiol. 2005 Jun;43(6):2771-81. doi: 10.1128/JCM.43.6.2771-2781.2005.
10
Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11404-9. doi: 10.1073/pnas.0402391101. Epub 2004 Jul 26.
引用本文的文献
1
Guillain-Barré syndrome, transverse myelitis and infectious diseases.
Cell Mol Immunol. 2018 Jun;15(6):547-562. doi: 10.1038/cmi.2017.142. Epub 2018 Jan 29.
2
Genome analysis of Campylobacter jejuni strains isolated from a waterborne outbreak.
BMC Genomics. 2014 Sep 8;15(1):768. doi: 10.1186/1471-2164-15-768.
3
Comparative genotyping of Campylobacter jejuni strains from patients with Guillain-Barré syndrome in Bangladesh.
PLoS One. 2009 Sep 30;4(9):e7257. doi: 10.1371/journal.pone.0007257.
4
Correlation between genotypic diversity, lipooligosaccharide gene locus class variation, and caco-2 cell invasion potential of Campylobacter jejuni isolates from chicken meat and humans: contribution to virulotyping.
Appl Environ Microbiol. 2009 Jul;75(13):4277-88. doi: 10.1128/AEM.02269-08. Epub 2009 May 1.
5
Comparative genomic assessment of Multi-Locus Sequence Typing: rapid accumulation of genomic heterogeneity among clonal isolates of Campylobacter jejuni.
BMC Evol Biol. 2008 Aug 8;8:229. doi: 10.1186/1471-2148-8-229.
6
Baseline data from a Belgium-wide survey of Campylobacter species contamination in chicken meat preparations and considerations for a reliable monitoring program.
Appl Environ Microbiol. 2008 Sep;74(17):5483-9. doi: 10.1128/AEM.00161-08. Epub 2008 Jul 11.
7
Comparative genomic analysis of clinical strains of Campylobacter jejuni from South Africa.
PLoS One. 2008 Apr 23;3(4):e2015. doi: 10.1371/journal.pone.0002015.
本文引用的文献
1
Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
Infect Immun. 2007 Mar;75(3):1245-54. doi: 10.1128/IAI.00872-06. Epub 2007 Jan 29.
2
Identification of a sialate O-acetyltransferase from Campylobacter jejuni: demonstration of direct transfer to the C-9 position of terminalalpha-2, 8-linked sialic acid.
J Biol Chem. 2006 Apr 28;281(17):11480-6. doi: 10.1074/jbc.M512183200. Epub 2006 Feb 14.
3
Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Neurology. 2005 Nov 8;65(9):1376-81. doi: 10.1212/01.wnl.0000176914.70893.14. Epub 2005 Sep 14.
4
Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources.
J Clin Microbiol. 2005 Jun;43(6):2771-81. doi: 10.1128/JCM.43.6.2771-2781.2005.
5
The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
J Clin Invest. 2004 Dec;114(11):1659-65. doi: 10.1172/JCI15707.
6
The Guillain-Barré syndrome: a true case of molecular mimicry.
Trends Immunol. 2004 Feb;25(2):61-6. doi: 10.1016/j.it.2003.12.004.
7
Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Infect Immun. 2002 Mar;70(3):1202-8. doi: 10.1128/IAI.70.3.1202-1208.2002.
8
The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide.
J Biol Chem. 2002 Jan 4;277(1):327-37. doi: 10.1074/jbc.M108452200. Epub 2001 Oct 31.
9
A Campylobacter jejuni gene associated with immune-mediated neuropathy.
Nat Med. 2001 Jul;7(7):752-3. doi: 10.1038/89831.
10
Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides.
J Infect Dis. 1997 Dec;176 Suppl 2:S115-21. doi: 10.1086/513781.
Zotero 插件